Skip to main content
Premium Trial:

Request an Annual Quote

Asterand and Rubicon Genomics to Co-Develop Cancer Diagnostics

NEW YORK, June 27 (GenomeWeb News) - Asterand said today that it will partner with Rubicon Genomics to discover novel biomarkers for cancer diagnosis.


Under the non-exclusive agreement, Asterand will supply tissue and biofluid samples from its biorepository and its worldwide network of clinical collaborators, and Rubicon will study the samples using its MethylPlex technology to discover methylated DNA markers for cancer diagnosis and prognosis.


Asterand will be eligible to receive royalties on diagnostic tests developed under the collaboration. Further financial details were not disclosed.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.